MB
MPM BioImpact Portfolio holdings
AUM
$577M
This Quarter Return
+11.01%
1 Year Return
+8.33%
3 Year Return
+241.63%
5 Year Return
+127.38%
10 Year Return
–
AUM
$385M
AUM Growth
+$385M
(-0.14%)
Cap. Flow
+$13.9M
Cap. Flow
% of AUM
3.62%
Top 10 Holdings %
Top 10 Hldgs %
70.32%
Holding
34
New
1
Increased
10
Reduced
11
Closed
3
Top Buys
| 1 |
Relay Therapeutics
RLAY
|
$20.2M |
| 2 |
PRVB
Provention Bio, Inc. Common Stock
PRVB
|
$6.64M |
| 3 |
Intellia Therapeutics
NTLA
|
$4.37M |
| 4 |
Iovance Biotherapeutics
IOVA
|
$2.84M |
| 5 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$2.73M |
Top Sells
| 1 |
uniQure
QURE
|
$11.9M |
| 2 |
Harmony Biosciences
HRMY
|
$7.68M |
| 3 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
$3.53M |
| 4 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$1.78M |
| 5 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$1.62M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HARP
26
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $2.38M | 0.62% |
3,196,707
| – | – |
|
27
Phathom Pharmaceuticals
PHAT
$843M
| $1.52M | 0.39% |
212,615
+16,673
| +9% | +$119K |
|
|
INZY
28
DELISTED
Inozyme Pharma
INZY
| $1.34M | 0.35% |
233,728
+3,228
| +1% | +$18.5K |
|
|
ONCR
29
DELISTED
Oncorus, Inc.
ONCR
| $818K | 0.21% |
2,377,031
| – | – |
|
|
TECX
30
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
| $648K | 0.17% |
647,918
| – | – |
|
31
Black Diamond Therapeutics
BDTX
$164M
| $274K | 0.07% |
144,888
| – | – |
|
|
GTHX
32
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| – | – |
-650,000
| Closed | -$3.53M |
|
33
Praxis Precision Medicines
PRAX
$980M
| – | – |
-610,000
| Closed | -$1.45M |
|
|
34
Harmony Biosciences
HRMY
$2.16B
| – | – |
-139,377
| Closed | -$7.68M |
|